Immuneering Corp (IMRX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: IMRX Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	398,600 -12.1% 2.90 1,155,940 USD	398,600 -12.1%	2.90	1,155,940 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	280 -0.0% 2.97 832 USD	280 -0.0%	2.97	832 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	10 -0.0% 2.98 30 USD	10 -0.0%	2.98	30 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	10 -0.0% 3.01 30 USD	10 -0.0%	3.01	30 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	600 -0.0% 3.03 1,818 USD	600 -0.0%	3.03	1,818 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	100 -0.0% 3.05 305 USD	100 -0.0%	3.05	305 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	300 -0.0% 3.07 920 USD	300 -0.0%	3.07	920 USD
2024-04-03	2024-04-01	S Sale	Cormorant Asset Management, LP Major owner	100 -0.0% 3.07 307 USD	100 -0.0%	3.07	307 USD
2024-03-25	2024-03-22	B Purchase	Schall Thomas J. Non-Executive Director	2,900 +inf% 2.55 7,385 USD	2,900 +inf%	2.55	7,385 USD
2024-03-25	2024-03-22	B Purchase	Feinberg Peter Non-Executive Director	25,000 +28.8% 2.55 63,713 USD	25,000 +28.8%	2.55	63,713 USD
2024-03-25	2024-03-22	B Purchase	Brakewood Harold Eugene Chief Business Officer Officer	3,900 +inf% 2.57 10,015 USD	3,900 +inf%	2.57	10,015 USD
2024-03-25	2024-03-22	B Purchase	Morales Mallory Chief Accounting Officer Officer	393 +5.0% 2.55 1,000 USD	393 +5.0%	2.55	1,000 USD
2024-03-25	2024-03-21	B Purchase	Morales Mallory Chief Accounting Officer Officer	1,107 +16.3% 2.72 3,009 USD	1,107 +16.3%	2.72	3,009 USD
2024-03-21	2024-03-20	B Purchase	Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer	7,000 +2.1% 2.86 20,020 USD	7,000 +2.1%	2.86	20,020 USD
2024-03-21	2024-03-20	B Purchase	Neufeld Leah R CHIEF PEOPLE OFFICER Officer	3,818 +61.5% 2.88 10,993 USD	3,818 +61.5%	2.88	10,993 USD
2024-03-19	2024-03-19	B Purchase	Feinberg Peter Non-Executive Director	25,000 +40.5% 2.56 64,000 USD	25,000 +40.5%	2.56	64,000 USD
2024-03-19	2024-03-19	B Purchase	Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Major owner	20,000 +0.9% 2.77 55,326 USD	20,000 +0.9%	2.77	55,326 USD
2024-03-19	2024-03-18	B Purchase	Feinberg Peter Non-Executive Director	4,976 +8.8% 3.05 15,201 USD	4,976 +8.8%	3.05	15,201 USD
2024-03-19	2024-03-18	B Purchase	Feinberg Peter Non-Executive Director	45,024 +382.7% 2.31 103,857 USD	45,024 +382.7%	2.31	103,857 USD
2024-03-19	2024-03-18	B Purchase	BERMAN ANN E Non-Executive Director	57,965 +610.2% 2.13 123,436 USD	57,965 +610.2%	2.13	123,436 USD
2024-03-18	2024-03-15	S Sale	Cormorant Asset Management, LP Major owner	400,000 -10.8% 2.14 856,400 USD	400,000 -10.8%	2.14	856,400 USD
2024-03-18	2024-03-14	S Sale	Cormorant Asset Management, LP Major owner	11,040 -0.3% 5.97 65,887 USD	11,040 -0.3%	5.97	65,887 USD
2024-03-18	2024-03-14	S Sale	Cormorant Asset Management, LP Major owner	54,215 -1.4% 5.37 291,351 USD	54,215 -1.4%	5.37	291,351 USD
2024-03-18	2024-03-14	S Sale	Cormorant Asset Management, LP Major owner	98,570 -2.6% 4.25 418,430 USD	98,570 -2.6%	4.25	418,430 USD
2024-03-18	2024-03-14	S Sale	Cormorant Asset Management, LP Major owner	345,266 -8.2% 3.24 1,116,936 USD	345,266 -8.2%	3.24	1,116,936 USD
2022-05-27	2022-05-25	B Purchase	Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer	2,551 +0.8% 3.92 10,000 USD	2,551 +0.8%	3.92	10,000 USD
2022-05-18	2022-05-17	B Purchase	Bookman Michael GENERAL COUNSEL AND SECRETARY Officer	1,000 +71.3% 4.88 4,880 USD	1,000 +71.3%	4.88	4,880 USD
2022-05-17	2022-05-16	B Purchase	KEATING LAURIE Non-Executive Director	7,000 +100.0% 5.00 35,000 USD	7,000 +100.0%	5.00	35,000 USD
2022-05-12	2022-05-12	B Purchase	Amin Biren CFO, TREASURER Officer	1,000 +14.5% 4.42 4,420 USD	1,000 +14.5%	4.42	4,420 USD
2022-03-24	2022-03-23	B Purchase	Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Major owner	3,000 +0.1% 8.02 24,060 USD	3,000 +0.1%	8.02	24,060 USD
2022-03-23	2022-03-23	B Purchase	Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Officer	1,050 +0.3% 7.91 8,306 USD	1,050 +0.3%	7.91	8,306 USD
2022-03-22	2022-03-22	B Purchase	Barrett Scott CHIEF MEDICAL OFFICER Officer	900 +13.5% 7.49 6,737 USD	900 +13.5%	7.49	6,737 USD
2022-03-16	2022-03-15	B Purchase	Feinberg Peter Non-Executive Director	6,667 +130.8% 6.75 45,002 USD	6,667 +130.8%	6.75	45,002 USD
2022-03-15	2022-03-15	B Purchase	BERMAN ANN E Non-Executive Director	6,000 +171.4% 6.40 38,400 USD	6,000 +171.4%	6.40	38,400 USD
2021-09-14	2021-09-13	B Purchase	Zeskind Benjamin J. PRESIDENT AND CEO Executive Director Major owner	2,083 +0.1% 22.87 47,632 USD	2,083 +0.1%	22.87	47,632 USD
2021-08-04	2021-08-03	B Purchase	Feinberg Peter Non-Executive Director	33,333 +40.6% 15.00 499,995 USD	33,333 +40.6%	15.00	499,995 USD
2021-08-04	2021-08-03	B Purchase	Feinberg Peter Non-Executive Director	129,167 +37.2% 15.00 1,937,505 USD	129,167 +37.2%	15.00	1,937,505 USD
2021-08-04	2021-08-03	B Purchase	Feinberg Peter Non-Executive Director	129,167 +50.2% 15.00 1,937,505 USD	129,167 +50.2%	15.00	1,937,505 USD
2021-08-04	2021-08-03	B Purchase	Amin Biren CFO, Treasurer Officer	4,175 +153.3% 15.00 62,625 USD	4,175 +153.3%	15.00	62,625 USD